Risperdal Boys Breasts Lawsuits – Current Risperdal Gynecomastia Lawsuit Information
Men and boys who have suffered from abnormal breast growth as a result of Risperdal may have legal grounds to file a Risperdal male breast lawsuit. This page provides thorough information about the precedence for Risperdal lawsuits and who is eligible to file a Risperdal gynecomastia lawsuit.
Risperdal Boys Breast Growth Lawsuits
If you or a family member developed male breasts while taking Risperdal, you may have legal grounds for filing a Risperdal gynecomastia lawsuit. Filing a Risperdal lawsuit serves two purposes:
First, a lawsuit can achieve financial compensation for your family for the suffering, damages, and medical expenses encountered as a result of Risperdal breast growth. The effects of Risperdal boys breast development cannot be understated; psychologists say that boys and men who grow breasts from Risperdal can suffer from self-loathing, shame, anxiety, depression, and social isolation for years, symptoms that can have a detrimental impact on the future trajectory of a person’s life.
Second, an onslaught of Risperdal breast growth lawsuits may be the only recourse consumers have for pressing Johnson & Johnson for greater safety accountability to consumers. As Risperdal gynecomastia lawsuits band together in a Multi-District Litigation (MDL), individual consumers join strength against a pharmaceutical giant to pursue justice and safeguard others against the same dangers in the future.
Our attorneys handle Risperdal male breast lawsuits throughout the United States, and offer no-cost, no-obligation Risperdal gynecomastia lawsuit case review for persons anywhere in the country who grew male breasts while taking Risperdal. To discuss your situation in detail with an attorney and to learn about Risperdal lawsuit time limits in your state, please complete our online contact form. One of our attorneys handling Risperdal boys breast growth lawsuits will contact you promptly.
About Risperdal Lawsuits
Johnson & Johnson has already faced a string of significant Risperdal boys breast growth lawsuits. The Risperdal breast growth lawsuit claims stem from a number of complaints. First, Johnson & Johnson and its pharmaceutical Janssen promoted the drug for off-label uses, marketing Risperdal to mental health providers for use in children and teens long before the drug was approved for such uses in 2007. Risperdal was also widely promoted for off-label uses in the elderly and persons with mental health diagnoses, offering monetary kickbacks in the tens of millions to companies that used Risperdal for its patients. Another assertion brought forward by more than one Risperdal gynecomastia lawsuit is that the company downplayed the connection between Risperdal and boys breast growth, as well as the damage that can be caused by gynecomastia. Referring to the Department of Justice’s Risperdal lawsuit, which resulted in the third-largest pharmaceutical settlement in U.S. history ($2.2 billion), Attorney General Eric Holder asserted,“The conduct at issue in this case jeopardized the health and safety of patients and damaged the public trust.”
Johnson & Johnson has paid extensive civil and criminal fines as a result of Risperdal male breast lawsuits that have already settled. Johnson & Johnson’s flagrant violations of federal and state regulations suggest that the fines the pharmaceutical giant has paid to settle Risperdal gynecomastia lawsuits and false advertising lawsuits are merely the cost of doing business, asserts an article from the Citizen’s Commission on Human Rights:
“Millions paid in claims are a drop in [Johnson & Johnson’s] profit bucket.”
The company has neglected to comment specifically on the violations brought to light in Risperdal lawsuits, continuing to assert that the drug is safe. The Citizen’s Commission on Human Rights suggests that it will take a major Federal Risperdal lawsuit and “lots of media attention to force the FDA and Johnson and Johnson to pull this drug from the market”.
Risperdal Male Breast Development Lawsuits Are Not Class Action Lawsuits
Many persons who have grown male breasts while taking Risperdal wonder if filing a Risperdal gynecomastia lawsuit will bring about meaningful compensation for their family. Risperdal male breast development lawsuits are not class action lawsuits, in which each plaintiff can expect to receive only a small, symbolic settlement. Risperdal gynecomastia lawsuits will likely join forces into a Multi-District Litigation (MDL), in which each case will be considered on its own merit and each plaintiff will receive compensation based on the particulars of their situation and degree of suffering.
Our firm represents all persons involved in a Risperdal boys breast lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation, complete our brief online contact form. One of our Risperdal breast development lawyers will contact you shortly to answer your questions as definitely as possible.
No-Cost, No-Obligation Risperdal Lawsuit Case Review for Persons or Families of Persons Who Grew Male Breasts while Taking Risperdal
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. We have represented clients throughout the United States in complex pharmaceutical litigation such as Vioxx, Digitek, Ethex and others, and if you or a loved one has suffered from gynecomastia we will discuss your situation and answer as many of your questions as possible without any fee or further obligation. Should you wish our firm to represent you in a Rispderal breast growth lawsuit, we never charge a fee unless we are able to collect for you.